Quantity size:
0.2ml
Concentration:
1mg/ml 死亡受体4抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Apoptosis, or programmed cell death, occurs during normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by certain cytokines including TNF and Fas ligand of the TNF family through their death domain containing receptors, TNFR1 and Fas. A novel cell death receptor was recently identified and designated DR4 (for d死亡受体4抗体eath receptor 4). The ligand for this novel death receptor has been identified and termed TRAIL, which is a new member in the TNF family. DR4 is also called TRAIL receptor 1(TRAIL R1). DR4 is expressed in most of human tissues including spleen, peripheral blood leukocytes, small intestine and thymus. Like TNFR1, Fas and DR3, DR4 mediates apoptosis and NF kB activation in many tissues and cells.
死亡受体4抗体Also known as:
Apo 2; Apo2; CD 261; CD261; CD261 antigen; Cytotoxic ligand TRAIL receptor; Cytotoxic TRAIL receptor; Death receptor 4; DR 4; DR4; MGC9365; NF related apoptosis-inducing ligand receptor 1; T10A; TNF related apoptosis inducing ligand receptor 1; TNFRSF10A; TRAIL R1; TRAIL receptor 1; TRAILR 1; TRAILR1; Tumor necrosis factor receptor superfamily member 10a;死亡受体4抗体 Tumor necrosis factor receptor superfamily member 10A precursor; TR10A_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated synthetic peptide derived from human DR4.
●
死亡受体4抗体Predicted Molecular Weight: 48kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl785Mu01肾损伤分子1(Kim1)多克隆抗体Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
kl785Ra01肾损伤分子1(Kim1)多克隆抗体Polyclonal Antibody to Kidney Injury Molecule 1 (Kim1)
kl786Hu01纤维胶凝蛋白1(FCN1)多克隆抗体Polyclonal Antibody to Ficolin 1 (FCN1)
kl786Mu01纤维胶凝蛋白1(FCN1)多克隆抗体Polyclonal Antibody to Ficolin 1 (FCN1)
kl788Hu01细胞程序性死亡蛋白1配体1(PDCD1LG1)多克隆抗体Polyclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDCD1LG1)
kl788Mu01细胞程序性死亡蛋白1配体1(PDCD1LG1)多克隆抗体Polyclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDCD1LG1)
kl791Mu01骨粘连蛋白(ON)多克隆抗体Polyclonal Antibody to Osteonectin (ON)
kl791Ra01骨粘连蛋白(ON)多克隆抗体Polyclonal Antibody to Osteonectin (ON)
kl792Hu01拓扑异构酶Ⅱ(TOP2)多克隆抗体Polyclonal Antibody to Topoisomerase II (TOP2)
kl794Hu01周期素依赖性激酶抑制因子2A(CDKN2A)多克隆抗体Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
kl794Mu01周期素依赖性激酶抑制因子2A(CDKN2A)多克隆抗体Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)
kl796Hu01神经肽S(NPS)多克隆抗体Polyclonal Antibody to Neuropeptide S (NPS)
kl796Mu01神经肽S(NPS)多克隆抗体Polyclonal Antibody to Neuropeptide S (NPS)
kl796Ra01神经肽S(NPS)多克隆抗体Polyclonal Antibody to Neuropeptide S (NPS)
kl797Hu01血管紧张素原(AGT)多克隆抗体Polyclonal Antibody to Angiotensinogen (AGT)
kl797Mu01血管紧张素原(AGT)多克隆抗体Polyclonal Antibody to Angiotensinogen (AGT)
kl797Ra01血管紧张素原(AGT)多克隆抗体Polyclonal Antibody to Angiotensinogen (AGT)
kl798Hu01低氧诱导因子1α(HIF1α)多克隆抗体Polyclonal Antibody to Hypoxia Inducible Factor 1 Alpha (HIF1a)
kl798Mu01低氧诱导因子1α(HIF1α)多克隆抗体Polyclonal Antibody to Hypoxia Inducible Factor 1 Alpha (HIF1a)
kl798Po01低氧诱导因子1α(HIF1α)多克隆抗体Polyclonal Antibody to Hypoxia Inducible Factor 1 Alpha (HIF1a)
kl798Ra01低氧诱导因子1α(HIF1α)多克隆抗体Polyclonal Antibody to Hypoxia Inducible Factor 1 Alpha (HIF1a)
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话